Rapid Diagnostics for TB: Faster, smarter tests for people in high-burden areas
Official title: Rapid Research for Diagnostics Development in TB Network: Episode 2 (R2D2 TB Network II)
Funded at University of California, San Francisco · NIH-11607818 · Data updated 2026-11-12
A network-backed effort to bring new TB diagnostic tools to patients in high-burden countries so they get diagnosed faster and treated effectively.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project start | September 11, 2025 |
| Project end | August 31, 2030 |
| Funding year | 2026 |
| Award (this year) | $615,312 |
| NIH project number | 3R01AI190419-02S3 |
| Project ID | NIH-11607818 on NIH RePORTER |
Who could benefit from this research
✓Could help
Individuals at risk for TB or with suspected TB, in high-burden settings, where existing diagnostics are limited.
✕Less likely to help
Patients in settings with already optimized diagnostic pathways or no access issues may see limited direct benefit.
What this research studies
This grant supports building and coordinating a network to identify promising TB diagnostic technologies, connect them with experienced clinical sites, and help evaluate their performance in real-world settings. The project aims to tailor test development to different use cases and health system levels, with feedback loops to improve tools before widespread deployment. By linking tech innovators with clinical partners, it seeks to shorten the time from symptom onset to accurate diagnosis and appropriate treatment for people with TB. EFfective collaboration with a biotech incubator will streamline technology maturation and real-world testing.
Why it matters
Potential benefit: If successful, patients could receive faster and more accurate TB diagnoses, leading to timely treatment and reduced transmission.
How similar studies have gone: Past efforts have shown that linking developers with clinical sites can accelerate evaluation and adoption of new TB tests.
Where this research is happening
-
University of California, San Francisco
San Francisco, United States Active
Researchers
- Principal investigator: Nahid, Payam — University of California, San Francisco
- Study coordinator: Nahid, Payam
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.